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ABSTRACT: 
Background: Liver cirrhosis has become one of the major causes of morbidity and mortality. The burden of liver 
cirrhosis is growing in both the West and the East. In Pakistan death rate of liver cirrhosis is conspicuous because 
of chronic hepatitis (hepatitis B, C) and hepatocellular carcinoma. It is reported by World Health Organization that 
Pakistan occupies secondary place in spread of hepatitis C. 
Objective: To compare the portal vein diameter in cirrhotic and non-cirrhotic patients through ultrasound. 
Methodology: Ultrasound machine Toshiba Xario, Mindray dp 10 and G logic p5 with a curvilinear transducer of 
frequency 3.5 MHz was used. The study was conducted at, Hussain Diagnostic Ultrasound Centre Jampur, District 
Rajanpur. Data of 100 patients was collected through Cross-Sectional Analytical study. Statistical software for 
social sciences (SPSS version 22.0) is used for the analysis of data.  
Results: One hundred patients participated in this study. Among them, the minimum age was 30 and the maximum 
age was 70. Ratio of male patients was more than female patients, due to fact of more alcohol consumption in 
males. Out of 100 patients, 50 patients had cirrhosis and 50 were non cirrhotic. Liver cirrhosis patients came the 
severe symptoms like weakness, lethargy, hematemesis and melena. Non cirrhotic patients came with epigastric 
pain, nausea and vomiting. Mean of Portal vein diameter in non-cirrhotic patients was 10.5mm. Mean of  Portal 
vein diameter in live cirrhosis patients was 14.8mm. A statistical significance difference was found between the 
two means of portal vein diameter of two groups (cirrhotic and non-cirrhotic) as the p-value 0.000 less than 0.05.  
Conclusion: Liver cirrhosis is one of the major issues of health and a big reason for increasing mortality rate all 
over the world. The most common etiology of liver cirrhosis .is .alcohol. Patients come with liver cirrhosis having 
severe symptoms like weakness, lethargy, hematemesis and melena. Non-cirrhotic patients come with mild 
symptoms like epigastric pain, nausea and vomiting, having normal portal vein diameter. Mean portal vein 
diameter in cirrhotic patients (14.8mm) was greater than non-cirrhotic patients (10.5mm).   
Key words: Liver cirrhosis, Non-alcoholic steatohepatitis (NASH), Non- alcoholic fatty liver disease (NAFLD), 
alcoholic liver disease (ALD). 
DOI: 10.7176/JHMN/76-12 
Publication date:June 30th 2020 
 
INTRODUCTION:  
Liver cirrhosis is one of the major issues of health and a big reason for increasing mortality rate all over the 
world. According to Global Burden of Disease (GBD) over one million people died due to cirrhosis in 2010 
worldwide.1 According to autopsy studies worldwide occurrence of cirrhosis, measured from 4.5% to 9.5% in 
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ubiquitous community. In 2001, the evaluated universal death rate from cirrhosis was 771,000 population, 
grading 14th and 10th as the foremost etiology of demise in the domain and in advanced nations, appropriately. 
Cirrhosis will be a 12th major issue of demise in 2020. Universally, usual etiologies of cirrhosis are viral hepatitis, 
alcohol, non-alcoholic steatohepatitis (NASH). Preponderance of cirrhosis is possibly to be underrated as about 
a 3rd of the sufferers remain undetermined.2  
Cirrhosis is the main cause of illness and fatality in the United States. It was specified by Centers for Disease 
Control and Prevention that cirrhosis was the 12th key factor of demise in the United States in 2013, reporting 
for over 36,000 deaths. Non- alcoholic fatty liver disease (NAFLD) is the superiorly significant source of 
cirrhosis. Alcohol remains to be one of the large donors to hepatic disorder in the United States. It is clear that 
alcoholic liver disease (ALD) is the greatest etiology of cirrhosis in whites. According to recent data from the 
National Institute on Alcohol Abuse and Alcoholism demonstrated that whites are mostly expire from alcoholic 
liver cirrhosis as compared to blacks.3 In Europe, about 0.1% of Hungarian males will die of cirrhosis every year 
compared with 0.001% of Greek females.4  
In Pakistan death rate of liver cirrhosis is conspicuous because of chronic hepatitis (hepatitis B, C) and 
hepatocellular carcinoma. It is reported by World Health Organization that Pakistan occupies secondary place 
in spread of hepatitis C. There are about 1,000,000 persistent patients of hepatitis B and 1,700,000 persistent 
patients of hepatitis C in Sind province of Pakistan. One main reason of death rate across Pakistani population 
is cirrhosis, typically the most frequent complexity of cirrhosis with portal hypertension are esophageal varices. 
Ascites were present in 59% of patients in Pakistan. Spontaneous bacterial peritonitis (SBP) contributes almost 
24 % of in death rate in Pakistan, mainly in Sindh. Universally 6th frequently occurring cancer is hepatic cancer; 
which affects every 12th male and every 4th female per 100,000 males and females respectively, in Pakistan. 
HCC broadly (96%) experienced in post cirrhotic liver in persistent hepatitis C diseased patients.5    
Liver carries out a series of activities that assist metabolism, immunity, digestion, detoxification, vitamin storage 
among other activities.6 Its main tasks are to detoxify various metabolites, synthesize proteins, and generate 
enzymes essential for digestion. The liver also has an important role in metabolism, management of red blood 
cells (RBCs) and glucose composition and retention.7 The liver gathers its blood delivery from two resources: 
80% is supplied by the portal vein, which drains the spleen and intestines; the remaining 20%, the oxygenated 
blood, is supplied by the hepatic artery.8  
Cirrhosis is a significant deteriorative disease in which interchange of normal liver tissue with fibrous tissue 
takes place that results in distortion of liver anatomy and performance. In patients with persistent hepatic disease, 
portal hypertension and cirrhosis are obvious. Current progress in the interpretation of the usual report and 
morbid physiology of cirrhosis, and in cure of its problems, leading to enhanced administration, living standards 
and survival rate of cirrhotic patients. Now a days, the single remedial choice for a preferred panel of sufferers 
is liver transplantation, but progression of pharmacological drugs have sopped the development of 
decompensated cirrhosis or while converse cirrhosis are presently being augmented.9  
 
RESULTS 
One hundred patients participated in this study. Among them, the minimum age was 30 and the maximum age was 
70. Out of 100 patients, 50 patients had cirrhosis and 50 were non-cirrhotic. Patients came with liver cirrhosis had 
severe symptoms like weakness, lethargy, hematemesis and melena. Non-cirrhotic patients came with mild 
symptoms like of epigastric pain, nausea and vomiting.  Mean of Portal vein diameter in non-cirrhotic patients was 
10.5mm with standard deviation of 1.613. Mean of  Portal vein diameter in live cirrhosis patients was 14.8mm 
with standard deviation of 1.244, according to table 1. A statistical significance difference was found between the 
two means of portal vein diameter of two groups (cirrhotic and non-cirrhotic) as the p-value 0.000 less than 0.05, 
according to table 2. A detail description is given below 
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  N Mean(mm) Std. Deviation Std. Error Mean 
Non cirrhotic 50.000 10.550 1.613 0.228 
cirrhosis  50.000 14.890 1.244 0.176 
  
Table 1: Mean of portal vein diameter (PVD) in cirrhosis and non-cirrhotic patients. 
 
Mean 
Difference 
Std. Error 
Difference 
t df Sig. (2-tailed) 
Equal variances assumed -4.340 .288 -15.066 98.000 .000 
Equal variances not 
assumed 
-4.340 .288 -15.066 92.057 .000 
 
Table 2: Independent Samples Test 
DISCUSSION 
One hundred patients participated in our study. Among them, the minimum age was 30 and the maximum age was 
70. Out of 100 patients, 50 patients had cirrhosis and 50 were control. In current study, there were more male 
patients than female patients. A .study .done .by .Ndububa .et .al in 2010; .in .South-Western .Nigeria .on .145 
.patients .on .the .contribution .of .alcohol .to .development .of .CLD .had .more .males .(102) .than .females 
.(43)10. .A study of 108 CLD patients by Kamran et al on correlation between sonographic PV diameter and flow 
velocity in cirrhotic patients also had more males (66) than females (42).      
 
In .our .study, .the .most .common .etiology .of .cirrhosis .was .alcohol. .General .symptoms .found .in .our 
.cirrhotic .patients .were weakness, hematemesis and melena. Non cirrhotic patients came with the symptoms of  
epigastric pain, vomiting, weakness and nausea. 
 
Maaji .et .al in 2016 also .had .male .predominance .in .his .study .on .sonographic .findings .of .CLD .patients .in 
Sokoto. .These .findings .concorded .with .this .study .confirming .male .predominance .in .CLD .in .our 
environment. .The .male .dominance .in .this .study .was .possibly .due .to .high .alcohol .intake .and .increased 
risk .of .hepatitis .B .infection .which .increases .the .risk .of .the .disease11. In our study male dominance was 
also seen. 
 
In current study, mean of portal vein diameter in patients with non-cirrhotic came 10.5 with standard deviation of 
1.613. Mean of portal vein diameter in patients with live cirrhosis came 14.8 with standard deviation of 1.244, 
according to table 15 and figure 4. Similar findings were found by other researchers. A .study .done .by Lopamudra 
et .al.in 2011 on .82 .CLD .patients .found .a .higher .value .of .mean .PV .diameter .of .13.99 .± .1.12 mm12. 
Nizar .et .al. .also .reported .an .increased .PV .diameter .of .up .to .17 .mm13. .In .another .study Rina Mohanty 
et al 2017 on .107 .CLD .patients .also .found .an .increase .in .diameter .of .the .extrahepatic .PV .which .was .>13 
mm14. .Similar .studies .done .also .showed .increase .in .diameter .of .the .main .PV. Hawaz Y in 2009, .studied 
the .mean .diameter .of .the .main .PV .in .CLD .patients .was .higher .(18.68 .± .2.59 .mm) .than .that .of .the 
control .(10.87 .± .0.81 .mm). .The .variation .in .the .values .of .the .main .PV .diameter .in .the .various .studies 
may .be .due .to .the .difference .in .sample .size, .ethnic .and .geographical .differences .between .the .populations 
studied15. .Hawaz .et .al.  .reported .an .increase .in .diameter .of .PV .with .increase .in .age .in .normal individuals 
which .is .consistent .with .the .finding .of .Anakwue .et .al done in 200915,17. .Similar .findings were .also .found 
by .many .researchers i.e, Shankar RG et al  in 2011 and by Subramanyam BR in 198918,19.                 
 
In current study, a statistical significance difference found between the two means of portal vein diameter of two 
groups (cirrhotic and non-cirrhotic) as the p-value 0.000 less than 0.05.  Aminu Umar Usman et al. .in .his .study 
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on .191 .CLD .patients .and .247 .controls .reported .no .difference .in .PV .diameter .values .between .male .and 
females .in .both .groups16. . .However, .Hawaz .et .al. .and .Anakwue .et .al.  .found .correlation .between .PV 
diameter .with .sex .in .CLD .patients, .but .they .found .no .correlation .between .PV .diameter .and .sex .in .normal 
subjects. .This .study .found .no .significant .difference .PV .diameter .in .male .and .females .in .CLD .patients (P 
.> .0.005). .However, .there .was .a .statistical .difference .in .the .control .group .(P .< .0.05) .with .values .slightly 
higher .in .females .than .males19,20. 
 
A .study .by . Shankar RG et al .on .50 .CLD .patients .and .50 .controls. This .study .found .a .significant difference 
between .right .and .left .PV .diameter .in .male .CLD .patients .and .control .group .(P .< .0.005). .No difference 
was, .however, .found .in .female .CLD .patients .(P .> .0.005)69. Bolondi L et al  .found .a .mean .portal .vein 
diameter .of .7 .± .1 .mm .among .normal .subjects .and .12 .± .2 .mm .among .cirrhotic .patients21. .Schepis .etlal 
10 .found .a .portal .vein .diameter .of .13.82 .± .2.1 .mm. .Prihatini .et .al 11 .concluded .in .their .study .that portal  
vein .size .1.2-cm22.  
 
 
 
Figure 1: TA gray scale image showing, portal vein diameter of 1.51cm. 
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Figure 2: TA gray scale image showing, portal vein diameter of 1.4cm. 
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